Teva Pharmaceutical Industries (TEV) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock TEV Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period UBS Maintains its Buy Rating on Teva Pharmaceutical Industries Limited (TEVA); Raises Its Price Target to $26.00October 1, 2025 | msn.comTeva Pharmaceutical Industries (NYSE:TEVA): Evaluating Valuation Potential After Recent Share MovementSeptember 21, 2025 | finance.yahoo.comJ.P. Morgan Maintains a Buy on Teva Pharmaceutical (TEVA) With a $23 PTSeptember 11, 2025 | finance.yahoo.comTeva Pharmaceutical Industries Ltd: Teva's Emrusolmin Granted U.S. FDA Fast Track Designation for Treatment of Multiple System AtrophySeptember 10, 2025 | finanznachrichten.deTeva’s emrusolmin granted U.S. FDA Fast Track designationSeptember 9, 2025 | msn.comTeva’s Emrusolmin Granted U.S. FDA Fast Track Designation for Treatment of Multiple System AtrophySeptember 9, 2025 | markets.businessinsider.comTeva (NYSE:TEVA) Valuation in Focus After FDA Approval and U.S. Launch of Generic SaxendaSeptember 6, 2025 | finance.yahoo.comDid FDA Approval of Generic Saxenda Just Shift Teva's (TEVA) Investment Narrative?August 30, 2025 | finance.yahoo.comAcadia Pharmaceuticals names Katcheves Chief Business and Strategy OfficerAugust 25, 2025 | msn.comPharma stocks higher as Trump backs down from 250% tariff threatAugust 22, 2025 | msn.comUS-EU trade deal impacts on pharma industry more 'manageable' than expectedAugust 22, 2025 | msn.comFollowing a 4.2% decline over last year, recent gains may please Teva Pharmaceutical Industries Limited (NYSE:TEVA) institutional ownersAugust 11, 2025 | finance.yahoo.comTeva Pharmaceutical Industries Limited (TEVA): A Bull Case TheoryAugust 7, 2025 | insidermonkey.comLeader Capital Markets Reiterates a Buy Rating on Teva Pharmaceutical Industries (TEVA)August 4, 2025 | msn.com7TEVA : A Glimpse of Teva Pharmaceutical Indus'...July 29, 2025 | benzinga.comTrump Aims Tariff Double Whammy at Industries, Nations by Aug. 1July 18, 2025 | msn.comGoldman Sachs Sticks to Its Buy Rating for Teva Pharmaceutical (TEVA)July 18, 2025 | theglobeandmail.comMore than 57,000 Bottles of a Cholesterol Medication Have Been Recalled in One StateJuly 18, 2025 | msn.comTeva Partners with Fosun Pharma to Advance Novel Cancer Immunotherapy TEV-56278July 9, 2025 | msn.comTeva Pharmaceutical Industries Ltd ADR Dividends - MorningstarJuly 8, 2025 | morningstar.comMTeva’s Ajovy Shows Sustained Long-Term Efficacy in Migraine Prevention TrialJuly 8, 2025 | msn.comTEVA - Teva Pharmaceutical Industries Ltd Chart - MorningstarJuly 5, 2025 | morningstar.comMTeva Pharmaceutical Industries Limited - Seeking AlphaJuly 3, 2025 | seekingalpha.comTeva Pharmaceutical Industries Ltd ADR - MorningstarJuly 3, 2025 | morningstar.comMTeva Pharmaceutical Industries Ltd: Teva to Host Conference Call to Discuss Second Quarter 2025 Financial Results at 8 a.m. ET on July 30, 2025 - FinanzNachrichten.deJune 27, 2025 | finanznachrichten.deTeva Pharmaceutical Industries Ltd: Teva Releases Q2 2025 Aide MemoireJune 26, 2025 | finanznachrichten.deTeva Pharmaceutical Industries Limited (TEVA): A Bull Case TheoryJune 25, 2025 | insidermonkey.comPM360 Announces 2025 Lifetime Achievement Award winnerJune 25, 2025 | finance.yahoo.comGoldman Sachs Starts Teva Pharma (TEVA) at Buy on Branded Drug GrowthJune 24, 2025 | uk.finance.yahoo.comTeva and Fosun partner to develop TEV-56278 against cancersJune 16, 2025 | msn.comTeva and Fosun Pharma Enter into a Strategic Partnership to Develop Novel Anti-PD1-IL2 Therapy (TEV-56278) in Immuno-OncologyJune 16, 2025 | finance.yahoo.comStocks Generating Improved Relative Strength: Teva Pharmaceutical ADRJune 9, 2025 | msn.comTeva 2024 Healthy Future Report: Health System Strengthening and Capacity BuildingJune 6, 2025 | finance.yahoo.comTeva Pharmaceutical Industries Limited (TEVA) Study Finds Gaps in Tardive Dyskinesia Care at Long-Term FacilitiesMay 31, 2025 | msn.comTeva Pharmaceutical Industries Limited (TEVA) Highlights Long-Acting Injectable Advancements for Schizophrenia at 2025 Psych CongressMay 31, 2025 | msn.comTeva Pharmaceutical Industries Ltd: Teva Celiac Disease Candidate Granted Fast Track Designation by US FDAMay 27, 2025 | finanznachrichten.deTeva Pharmaceutical Industries Limited (TEVA) Wins FDA Fast Track for Celiac Disease Drug TEV-53408May 27, 2025 | msn.comTeva Pharmaceutical Industries (NYSE:TEVA) Upsizes Senior Notes Offering to US$2.3 BillionMay 21, 2025 | finance.yahoo.comTeva Pharmaceutical Industries Ltd: Teva Announces $2,000,000,000 (Equivalent) Debt Tender Offers For Notes Due 2026-2031May 19, 2025 | finanznachrichten.deMoody’s upgrades Teva’s CFR to Ba1, maintains stable outlookMay 15, 2025 | investing.comWhy Teva Pharmaceutical Industries Limited (TEVA) Is the Best Affordable Stock Under $20 to BuyMay 15, 2025 | msn.comJP Morgan Upgrades Teva Pharmaceutical Industries Limited - Depositary Receipt () (TEVA)May 14, 2025 | msn.comWhy Teva Pharmaceuticals Stock Blasted 6% Higher TodayMay 12, 2025 | finance.yahoo.comTeva Pharmaceutical Industries Ltd (TEVA) Q1 2025 Earnings Call Highlights: Strong Growth in ...May 8, 2025 | finance.yahoo.comTeva to Host Innovation & Strategy Day on Thursday, May 29 in New York CityMay 7, 2025 | uk.finance.yahoo.comTeva Pharma shares rise as Q1 earnings beat estimates, guidance raisedMay 7, 2025 | au.investing.comTeva rises as forex impact drives Q1 revenue missMay 7, 2025 | msn.comTeva Pharm first-quarter profit rise tops estimatesMay 7, 2025 | msn.comTeva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI (ustekinumab-aekn) with Stelara (ustekinumab)May 6, 2025 | finanznachrichten.deProtalix BioTherapeutics' CFO Rubin to LeaveApril 23, 2025 | marketwatch.com Get Teva Pharmaceutical Industries News Delivered to You Automatically Sign up to receive the latest news and ratings for TEV and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TEV Media Mentions By Week TEV Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TEV News Sentiment▼0.410.54▲Average Medical News Sentiment TEV News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TEV Articles This Week▼12▲TEV Articles Average Week Get the Latest News and Ratings for TEV and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Teva Pharmaceutical Industries and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Genfit News Merck KGaA News ad pepper media International News Evotec News Fielmann Group News Fresenius SE & Co. KGaA News Sanofi News Sartorius Stedim Biotech News Siemens Healthineers News Bayer Aktiengesellschaft News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (FRA:TEV) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | SponsoredRefund From 1933: Trump’s Reset May Create Instant WealthGovernment Gridlock – The Final Act in a Collapse Trump's extension of this wealth saving loophole may be y...American Hartford Gold | SponsoredRIP USA"The America you knew is dying in front of you" That's the urgent warning the former $200 million hedge fun...Stansberry Research | SponsoredWall Street legend: “Sell this A.I. stock now”Whats next after AI? Hidden AI. "Hidden AI" could soon be the biggest investment trend of 2025.Chaikin Analytics | SponsoredThe next wave of AI fortunes may come from NVIDIA’s secret supplier.Bloomberg says AI is a $50 trillion revolution. And at the center of it… isn't NVIDIA. It's a tiny suppl...Behind the Markets | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Teva Pharmaceutical Industries Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Teva Pharmaceutical Industries With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
